Skip to content

Cannabis: all studies

Page 21 of 288: studies 201 to 210 of 2,878, newest first. Back to the cannabis overview

Research

Randomized trial of delta-9-tetrahydrocannabinol (THC) versus placebo to augment the effects of prolonged exposure therapy on fear extinction learning in post-traumatic stress disorder: Study rationale and protocol.

Contemporary Clinical Trials 2026 Christine A Rabinak, Paul E Kilgore, Mark A. Lumley et al.

Prolonged exposure (PE) therapy is effective for PTSD, yet dropout and partial response remain concerning. Preclinical and human studies suggest Δ9-tetrahydrocannabinol (THC) enhances fear extinction and recall through brain cannabinoid receptor activation in fear processing. Examine whether synthetic THC (dronabinol) augments PE effectiveness. Double-blind, placebo-controlled, trial with...

DOI: 10.1016/j.cct.2025.108148 (opens in new tab) Full text (opens in new tab) Delta9-Tetrahydrocannabinol THC Exposure therapy Extinction Memory +1

Regional and cannabis-related differences in prefrontal multiscale entropy of resting-state EEG.

Clinical Neurophysiology Practice 2026 William T Creel, Colleen A Brenner, Richard E Hartman

Entropy analysis of electroencephalographic (EEG) data provides insight into the complexity of neural activity. This study primarily examined whether cannabis use frequency is associated with alterations in multiscale entropy (MSE) in the prefrontal cortex (PFC) and mapped baseline MSE differences across cortical regions. Resting-state EEG was collected from 57 adults: non-users (n = 18),...

What Do Thirty Years of Neuroimaging Research Tell Us About Recreational Cannabis Use and Brain Integrity? A Narrative Review of the Multimodal Neuroimaging Evidence to Date.

Substance Abuse and Rehabilitation 2026 Ethan Murphy, Chao Suo, Govinda Poudel et al.

The consumption of cannabinoids is highly prevalent and has been associated with altered structural, functional, and metabolic brain integrity, measured using PET and neuroimaging tools. However, the current neuroimaging evidence has been summarized by distinct modalities that measure different metrics of brain integrity, precluding a comprehensive understanding of the underlying neurobiology....

Cannabis produces acute hyperphagia in humans and rodents via increased reward valuation for, and motivation to, acquire food.

Proceedings of the National Academy of Sciences December 30, 2025 Catherine Hume, Carrie Cuttler, Samantha L Baglot et al.

With approximately 4% of the world's population using cannabis, there is a need to better understand its physiological effects. Cannabis consumption acutely promotes food intake ("the munchies") via delta-9-tetrahydrocannabinol-mediated activation of cannabinoid 1 receptors (CB1R); however, these appetitive effects have not been well characterized. We examined effects of cannabis vapor...

Effects of ketamine enantiomers on morphine and THC subjective effects in rats.

Journal of Psychopharmacology December 26, 2025 Natalia Malikowska‐racia, Joanna Gołębiowska, Katarzyna Starowicz et al.

Ketamine, known for its rapid-acting antidepressant effects, is often coadministered with other psychoactive drugs, including opioids and cannabinoids, in both clinical and recreational settings. We investigated whether ketamine (R-, S-, or racemic R, S-) isoforms alter the subjective effects of morphine or Δ9-tetrahydrocannabinol (THC) and whether the interoceptive effects of ketamine overlap...

DOI: 10.1177/02698811251406839 (opens in new tab) Full text (opens in new tab) Addiction liability Ketamine optical isomers Subjective effects

Chronic cannabis use is associated with alterations in resting-state cerebellar-cortical connectivity.

Psychopharmacology December 12, 2025 Ilenia Salsano, Giorgia Picci, Nathan M Petro et al.

Cannabis is one of the most widely used psychoactive drugs in the United States, yet its long-term effects on brain function remain poorly understood. Prior resting-state functional connectivity (rsFC) studies have yielded inconsistent findings, likely due to variability in cannabis use thresholds, a predominant focus on younger populations, and region-of-interest (ROI)-based approaches limited...

Age and cannabis co-use are associated with differences in experience and perceived benefits of psilocybin: a retrospective study

December 10, 2025 Judith Hooper, Sarah Williams, Raeghan L. Mueller et al. 2 citations preprint

As psychedelic use increases, understanding how demographic and behavioral factors influence the effects of psychedelics is essential for both research and public health. This cross-sectional retrospective study examined 365 people who currently use psilocybin, analyzing differences in acute experiences, psychological outcomes, and substance co-use patterns. Participants were categorized into...

DOI: 10.31234/osf.io/dczw2_v2 (opens in new tab) Polysubstance dependence Young adult Retrospective cohort study Legalization +9

An astrocytic ensemble at vHip-NAc synapses modulates cognitive impairments induced by chronic tetrahydrocannabinol exposure.

Nature Communications December 9, 2025 Cristina Martín-Monteagudo, Javier Sánchez Romero, Julia Adams et al.

Cannabis is the most widely used illicit drug, particularly during adolescence. Its consumption disrupts glutamate homeostasis and synaptic plasticity in the nucleus accumbens (NAc). Here, we identify a functionally distinct accumbal astrocytic ensemble, associated with the ventral hippocampus-NAc (vHip→NAc) circuit, that is critical for tetrahydrocannabinol (THC)-induced synaptic and...

Association between lifetime co-use of classic psychedelics and cannabis and prostate cancer diagnosis among US adults 50 years and older

Scientific Reports December 8, 2025 Amrit Baral, Yue Pan, Wayway M. Hlaing et al.

Prostate cancer is the second leading cause of cancer-related deaths among U.S. men. While cannabis and classic psychedelics gain attention for symptom management in oncology, their associations with prostate cancer remain unexplored. This study evaluates associations between lifetime classic psychedelic and cannabis use with prostate cancer diagnoses among older U.S. adults using 2015-2019...

Tolerance but No Spontaneous Withdrawal Following Repeated THC Injections in Male and Female Rats

Cannabis and Cannabinoid Research December 1, 2025 Christa M. Hickey, Casey Poling, W. Grimes et al.

Introduction: Tolerance and dependence are known to occur with prolonged cannabis use. Few animal experiments on spontaneous withdrawal from delta-9-tetrahydrocannabinol (THC), the primary psychoactive compound in cannabis, have been conducted. The experiments that have been conducted use extremely high doses and report relatively mild symptoms. The objective of the present experiment was to...